Module II: Nuts and Bolts of Telehealth

Activity Details
  • Credit Type: CNE
  • Credit Amount: 0.50
  • Cost: Free
  • Release: May 2, 2022
  • Expires: May 1, 2025
  • Estimated Time to Complete:
    30 Minutes
  • Average User Rating:
    (1 Rating)


Sharon E.  Lock Sharon E. Lock, PhD, APRN, FNAP, FAANP, FAAN
Professor and Assistant Dean, Faculty Practice
UK College of Nursing
Lexington, Kentucky
Director, Wilmore Faculty Practice
Phyllis D. Corbitt Community Health Center
Wilmore, Kentucky

Needs Statement

Providing care via telehealth requires additional skills that are different from those used for in-person visits in primary care. This module will explore appropriate environment, etiquette and patient assessment for telehealth visits. Medicare reimbursement for telehealth visits will also be discussed.

Target Audience

Registered Nurses


After completing this module, the participant will be able to:

  1. Describe appropriate telehealth etiquette.
  2. Discuss the appropriate environment for a telehealth visit.
  3. Describe patient assessment during a telehealth visit.
  4. Discuss Medicare reimbursement for telehealth services.


In support of improving patient care, University of Kentucky HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The maximum number of hours awarded for this Continuing Nursing Education activity is 0.50 nursing contact hours.

Faculty Disclosure

All planners, faculty, and others in control of educational content are required to disclose all their financial relationships with ineligible companies within the prior 24 months. An ineligible company is defined as one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if the educational content an individual can control is related to the business lines or products of the ineligible company.

None of the planners, faculty, and others in control of educational content for this educational activity have relevant financial relationship(s) to disclose with ineligible companies.

The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include a discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when they are discussing investigational and/or off-label uses.

Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.


In collaboration with UK College of Nursing Continuing Education Office.